- 2019-04-03 08:26FDA green light for Merck's Mavenclad
- 2019-04-01 08:41As Remodulin copies roll, United Therapeutics faces big hit to its top seller
- 2019-04-01 08:41Communications Team of the Year strengthens its steering panel for the 2019 competition
- 2019-04-01 08:41UK Biotech still going strong at the start of 2019
- 2019-04-01 08:41LEO Pharma Chooses Veeva Development Cloud to Accelerate Drug Development
-
- 2019-04-01 08:41FDA approves treatment for patients with a type of inflammatory arthritis
- 2019-04-01 08:41RAPS on delayed Brexit
- 2019-04-01 08:41Novartis' MS drug gets FDA approval
- 2019-04-01 08:41Device-safety experts to FDA: Make data public
- 2019-03-28 15:11Novartis receives FDA approval for Mayzent® (siponimod), the first oral drug to treat secondary prog
-
- 2019-03-28 15:11Forxiga approved in Japan for type-1 diabetes
- 2019-03-28 15:11FDA rejects oral Type I diabetes drug
- 2019-03-28 15:11Japanese regulators hand first global approval to AbbVie, Boehringer Ingelheim's IL-23 inhibitor Sky
- 2019-03-28 15:01Alzheimer’s trial discontinued due to inefficiency
- 2019-03-28 15:01Cardiff Uni launches Medicines Discovery Institute
-
- 2019-03-28 15:01Rituximab found to extend progression-free survival in indolent lymphoma
- 2019-03-28 14:57Lewy Body Society grants £1 million for dementia research
- 2019-03-28 14:57Phase III results move Aimmune’s peanut allergy drug closer to EU market
- 2019-03-28 14:57Nearly half of British public regret not pursuing science-based career
- 2019-03-28 14:57Communications Team of the Year strengthens its steering panel for the 2019 competition
-
- 2019-03-28 14:57Fudan-Zhangjiang to be the First Applying Pharmaceutical Company, to Start the STIB Era of China’s P
- 2019-03-28 14:57In hiking prices, drugmakers show some signs of tempering increases
- 2019-03-28 14:57Shares in Proteostasis Therapeutics plunge on disappointing results for cystic fibrosis triplet ther
- 2019-03-28 14:57The 1st Chinese-produced Biosimilar Approved for Marketing
- 2019-03-28 14:57Theranica raises $35M to bring innovative migraine device to the USA
-
- 2019-03-28 14:57Celgene dodges Alvogen bid to overturn Revlimid patent
- 2016-01-13 08:38Interleukin-6 controls uterine Th9 cells to accelerate parturition in mice
- 2016-01-13 08:38Melanoma-derived factors alter the activation of differentiated tissue-resident dendritic cells
- 2016-01-13 08:38Impaired mTORC1-Dependent Expression of Homer-3 Influences SCA1 Pathophysiology
- 2016-01-13 08:38Haematopoietic ESL-1 enables stem cell proliferation by limiting TGFβ availability
-
- 2016-01-13 08:38Mouse Y-Encoded Transcription Factor Zfy2 Is Essential for Sperm Formation
- 2016-01-13 08:38Jubilant Biosys collaborates with Sanofi to develop metabolic disorders therapy
- 2016-01-13 08:38China's Zai Lab raises $100mn
- 2016-01-13 08:38Grünenthal and Akashi to develop HT-100 to treat DMD patients
- 2016-01-13 08:38Most top-selling, over-the-counter sexual treatments unproven, some could be harmful
-
- 2016-01-13 08:38Sanofi and Innate to develop new cancer drugs
- 2016-01-11 08:43Gilead Announces Top-Line Results From Two Phase 3 Studies Evaluating Tenofovir Alafenamide (TAF)
- 2016-01-11 08:43Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies
- 2016-01-11 08:43Positive top-line Phase IIa trial results for DS107 as a treatment for atopic dermatitis
- 2016-01-11 08:43Positive top-line results from the Japanese Phase II study of Traumakine® for the treatment of ARDS
-
- 2016-01-11 08:43Shimadzu Global Pharma Summit gathers veterans to share regulatory challenges
- 2016-01-11 08:43A cell-surface receptor protein proved the presence of stem cells in the ovary
- 2016-01-08 09:04Teikoku Pharma USA, Inc. Announces FDA Approval of Docetaxel Injection, Non-Alcohol Formula
- 2016-01-08 09:04TiGenix ends 2015 on a high after filing for Nasdaq IPO
- 2016-01-08 09:04Emergex to use Midatech nanoparticle tech for vaccines against infectious diseases
-
- 2016-01-08 09:04Face of Dermatology Industry Changing
- 2016-01-08 09:04Emperra Digital Diabetes Care Closes Series B Round With Robert Bosch Venture Capital GmbH Joining a
- 2016-01-08 09:04Novartis Pharmaceuticals collaborates with Qualcomm in digital innovation with the Breezhaler(TM) in
- 2016-01-08 09:04Antibody May Lower Rejection Rates After Stem Cell Transplant in Leukemia Patients
- 2016-01-08 09:04Phase 1 study of Verastem’s FAK inhibitor, VS-6063, starts
-
- SunSirs: On February 19th, the Price of Imported Potassium Chloride Fell by 1.80%
- SunSirs: Costs Rose and Supply Increased, DOTP Prices Were Weak Consolidated after the Holiday
- SunSirs: After the Holiday, Plasticizer Manufacturers Resumed Production and DOP Supply Increased
- SunSirs: Costs Rose, Supply Increased, and DBP Prices Weakly Consolidated
- SunSirs: Poor Replenishment, the Price of Aluminum Fluoride Was Temporarily Stable after the Holiday
- SunSirs: On February 18th, the Domestic DBP Market Was Temporarily Stable
- SunSirs: The Price of Tetrachloroethylene Has Fallen Narrowly after the Hholiday, and Expectations A
- SunSirs: Demand Was Weak, Production Was Resumed, and Acetic Anhydride Prices Dropped after the Holi
- SunSirs: Demand Was Weak, Production Was Resumed, and Acetic Anhydride Prices Dropped after the Holi
- SunSirs: China Fuel Oil 180CST Market in 2024 may Maintain a Volatile Trend
- SunSirs: The Demand Varies, China Gasoline has Higher Resistance to Drop Compared to Diesel
- SunSirs: Just Entering February, the Dimethyl Carbonate Market Was Operating Steadily and Weakly
- SunSirs: The Market Price of Lithium Hydroxide Was Mainly Stable (January 29-February 5)
- SunSirs: The Price of Nitric Acid Had Dropped This Week (January 29-February 2)
- SunSirs : The Cement Market Prices in Hunan have been Declining fo rFour Consecutive Weeks
- SunSirs: As the New Year Approaching, the Trend of the Market for Isooctyl Acrylate
- SunSirs: The Domestic First-class Titanium Sponge Market Was Mainly Operating Weakly and Steadily (J
- SunSirs: The Market Price of Ferrous Lithium Phosphate Fell in January
- SunSirs: The Price of Sodium Metabisulfite Was Weaker in January
- SunSirs: China Domestic Ship Fuel Market Fluctuated and Rose in January, 2024
- SunSirs: The Lithium Hydroxide Market in January First Fell and Then Stabilized
- SunSirs: The NMP Market Weakly Declined in January
- SunSirs: Summary of Domestic Cobalt Market Trends on January 18th
- SunSirs: On January 18th, Prices of Some Domestic Dysprosium Terbium Series Products Increased
- SunSirs: The Potassium Carbonate Market Has Declined This Week (January 15-19)
- SunSirs: The Release of Demand Side Was Slow, and the Market for Isooctyl Acrylate Was Stable
- SunSirs: The Seamless Tube Market Had Been Operating Weakly and Steadily This Week (January 8-12)
- SunSirs: Sales Were Sluggish, Propane Continued to Decline
- SunSirs: Production and Sales are Weak, China DME Market is temporarily Stable
- SunSirs: Weak consolidation of China MTBE market